Alex Yang

Directeur Général chez POLARYX THERAPEUTICS, INC.

Fortune : 74 M $ au 31/05/2026

56 ans

Commercial Services

Consumer Services

Health Technology

Profil

Alex Yang is currently Chairman & Chief Executive Officer at Polaryx Therapeutics, Inc. since 2023, Chairman & Chief Executive Officer at Epygenix Therapeutics, Inc., and Chief Executive Officer at Mstone Partners Hong Kong Ltd. Formerly, Mr. Yang was Managing Partner at Kim & Chang.
Education includes undergraduate studies at State University of New York at Binghamton and graduate studies at New York University School of Law.

Détentions connues dans des sociétés publiques

Société	Date	Nombre d'actions	Valorisation	Date de valorisation
POLARYX THERAPEUTICS, INC. 48,04 %	27/05/2026	22 744 796 ( 48,04 % )	74 M $	31/05/2026

Postes actifs de Alex Yang

Sociétés	Poste	Début
POLARYX THERAPEUTICS, INC.	Directeur Général	01/03/2023
Epygenix Therapeutics, Inc. Epygenix Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for neurological disorders	Directeur Général	-
Mstone Partners Hong Kong Ltd.	Directeur Général	-

Tous les postes actifs de Alex Yang

Anciens postes connus de Alex Yang

Sociétés	Poste	Fin
Kim & Chang Kim & Chang Miscellaneous Commercial ServicesCommercial Services Provides legal services	Corporate Officer/Principal	-

Voir l'expérience en détail de Alex Yang

Formation de Alex Yang

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Alex Yang

Sociétés liées

Entreprise privées	6
Kim & Chang Kim & Chang Miscellaneous Commercial ServicesCommercial Services Provides legal services	Commercial Services
State University of New York at Binghamton State University of New York at Binghamton Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
New York University School of Law New York University School of Law Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Mstone Partners Hong Kong Ltd.
Epygenix Therapeutics, Inc. Epygenix Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for neurological disorders	Health Technology
Polaryx Therapeutics, Inc. Polaryx Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage biotechnology company that engages in discovery, development and commercialization of novel, disease-modifying therapies for rare, pediatric lysosomal storage disorders	Commercial Services